“…However, the commercially available urease inhibitors, such as phosphorodiamidates, hydroxamic acid derivatives and imidazoles, are toxic and have poor stability, features that prevent their clinical use 7,8 . In addition to this, one of the reasons for the failure of H. pylori eradication in many countries is the increasing antibiotic resistance 2 . The prevalence of antibiotic-resistant H. pylori strains and the side effects associated with the present chemotherapeutic approach driven the search for alternatives to currently available anti-H. pylori drugs, especially regarding safe and effective non-antibiotic agents 9 .…”